Gut dysbiosis in cystic fibrosis

Journal of Cystic Fibrosis

Volumn 11, Issue 5, 2012, Pages 454-455

  Scanlan, Pauline D ^a   Buckling, Angus ^b   Kong, Weidong ^c   Wild, Yvette ^c   Lynch, Susan V ^c   Harrison, Freya ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF EXETER   (United Kingdom)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROBIOTIC AGENT;

BIFIDOBACTERIUM BREVE; CYSTIC FIBROSIS; ENTEROPATHY; FECES ANALYSIS; FECES MICROFLORA; GUT DYSBIOSIS; HUMAN; LETTER;

ANTI-BACTERIAL AGENTS; CYSTIC FIBROSIS; GASTROINTESTINAL DISEASES; GASTROINTESTINAL TRACT; HUMANS; METAGENOME; PILOT PROJECTS; PROBIOTICS; RESPIRATORY TRACT INFECTIONS; TREATMENT OUTCOME;

EID: 84866145985     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2012.03.007     Document Type: Letter

References (10)

1. Fujimura K.E., Slusher N.A., Cabana M.D., Lynch S.V. Role of the gut microbiota in defining human health. Expert Rev Anti Infect Ther 2010, 8:435-454.
2. Döring G., Bareth H., Gairing A., Wolz C., Botzenhart K. Genotyping of Pseudomonas aeruginosa sputum and stool isolates from cystic fibrosis patients: evidence for intestinal colonization and spreading into toilets. Epidemiol Infect 1989, 103:555-564.
3. Infante Pina D., Redecillas Ferreiro S., Torrent Vernetta A., Segarra Cantón O., Maldonado Smith M., Gartner Tizziano L., et al. Optimización de la función intestinal en pacientes con fibrosis quística mediante la administración de probióticos. An Pediatr (Barc) 2008, 69:501-505.
4. Bruzzese E., Raia V., Spagnuolo M.I., Volpicelli M., De Marco G., Maiuri L., et al. Effect of Lactobacillus GG supplementation on pulmonary exacerbations in patients with cystic fibrosis: a pilot study. Clin Nutr 2007, 26:322-328.
5. Weiss B., Bujanover Y., Yahav Y., Vilozni D., Fireman E., Efrati O. Probiotic supplementation affects pulmonary exacerbations in patients with cystic fibrosis: a pilot study. Pediatr Pulmonol 2010, 45:536-540.
6. Duytschaever G., Huys G., Bekaert M., Boulanger L., De Boeck K., Vandamme P. Cross-sectional and longitudinal comparison of the predominant fecal microbiota composition between a group of pediatric patients with cystic fibrosis and their healthy siblings. Appl Environ Microbiol 2011, 77:8015-8024.
7. Cox M.J., Huang Y.J., Fujimura K.E., Liu J.T., McKean M., Boushey H.A., et al. Lactobacillus casei abundance is associated with profound shifts in the infant gut microbiome. PLoS One 2010, 5:e8745.
8. Cox M.J., Allgaier M., Taylor B., Baek M.S., Huang Y.J., Daly R.A., et al. Airway microbiota and pathogen abundance in age-stratified cystic fibrosis patients. PLoS One 2010, 5:e11044.
9. Cox M.A.A., Cox T.F. Multidimensional scaling. Handbook of data visualization (Springer handbooks of computational statistics) 2008, Springer. C.-H. Chen, W. Härdle, A. Unwin (Eds.).
10. Heuvelin E., Lebreton C., Bichara M., Cerf-Bensussan N., Heyman M. A Bifidobacterium probiotic strain and its soluble factors alleviate chloride secretion by human intestinal epithelial cells. J Nutr 2010, 140:7-11.